Company Search:
Advanced Search
Sponsored Links
Sinopharm Group Co Ltd Company Snapshot
Sinopharm Group Co Ltd operates within the Drugs, proprietaries, and sundries sector. In addition to historical fundamental analyses, the complete report available to purchase compares Sinopharm Group Co Ltd with three other drug stores in Asia: Medipal Holdings Corporation of Japan (2018 sales of 3.15 trillion Japanese Yen [US$28.10 billion] of which 67% was Pharmaceuticals And Food Precessing Whol), Shanghai Pharmaceuticals Holding Co Ltd (159.08 billion Chinese Renmimbi [US$23.73 billion] ), and Alfresa Holdings Corporation which is based in Japan (2.60 trillion Japanese Yen [US$23.24 billion] of which 87% was Wholesale Business of Pharmaceuticals fo).

Sales Analysis. During the year ended December of 2018, sales at Sinopharm Group Co Ltd were 344.53 billion Chinese Renmimbi (US$51.39 billion). This is an increase of 24.1% versus 2017, when the company's sales were 277.72 billion Chinese Renmimbi. This was the fifth consecutive year of sales increases at Sinopharm Group Co Ltd (and since 2013, sales have increased a total of 106%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Sinopharm Group Co Ltd
  Stock Performance Chart for Sinopharm Group Co Ltd
  Stock Data: Recent Stock Performance:
  Current Price (4/18/2019): 26.98
(Figures in Chinese Renmimbi)
1 Week -2.1%   13 Weeks -5.4%  
4 Weeks -9.0%   52 Weeks -1.1%  
Sinopharm Group Co Ltd Key Data:
  Ticker: 1099 Country: China
  Exchanges: HKG Major Industry: Health Care Equipment & Services
    Sub Industry: Drugs, Proprietaries, & Sundries
  2018 Sales 344,525,821,000
(Year Ending Jan 2019).
Employees: 61,694
  Currency: Chinese Renmimbi Market Cap: 80,169,157,269
  Fiscal Yr Ends: December Shares Outstanding: 2,971,656,000
  Share Type: H Gu Closely Held Shares: 1,574,594,000
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.